EGFR Signaling in Colorectal Carcinoma
2011
EGFR Signaling in Colorectal Carcinoma
publication
Evidence: moderate
Author Information
Author(s): Alyssa M. Krasinskas
Primary Institution: University of Pittsburgh Medical Center
Hypothesis
The EGFR pathway and its impact on colorectal carcinogenesis and prognosis are the emphasis of this paper.
Conclusion
Alterations within the EGFR signaling cascade contribute to colorectal carcinogenesis and can impact prognosis.
Supporting Evidence
- EGFR is expressed in a variety of human tumors, including colorectal cancer.
- Mutations in the KRas gene are found in 30%–40% of colorectal cancers.
- BRAF mutations occur in 5–22% of all colorectal cancers.
Takeaway
This study talks about how a specific protein called EGFR is important in the growth of colon cancer and how changes in this protein can affect treatment outcomes.
Limitations
The significance of EGFR protein expression in colorectal cancer remains controversial due to varying detection methods.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website